Trials / Sponsors / YOUNGIL KOH
YOUNGIL KOH
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma Relapsed Refractory Multiple Myeloma (RRMM) | Phase 1 / Phase 2 | 2024-11-26 |